Literature DB >> 24731221

Role of Fbxw7 expression in hepatocellular carcinoma and adjacent non-tumor liver tissue.

Satoru Imura1, Lkhagva-Ochir Tovuu, Tohru Utsunomiya, Yuji Morine, Tetsuya Ikemoto, Yusuke Arakawa, Mami Kanamoto, Shuichi Iwahashi, Yu Saito, Chie Takasu, Shinichiro Yamada, Daichi Ishikawa, Yoshimi Bando, Mitsuo Shimada.   

Abstract

BACKGROUND AND AIM: Fbxw7 is a tumor suppressor gene through ubiquitination and degradation of multiple oncoproteins. Loss of Fbxw7 expression is frequently observed in various human cancers. In the present study, we examined the role of Fbxw7 expression in both non-tumor liver tissues and tumor tissues on clinicopathological significance.
METHODS: Sixty-six patients with hepatocellular carcinoma (HCC), who underwent hepatectomy, were divided into two groups: high and low gene-expression group, based on the Fbxw7 expression level. We compared the clinicopathological factors between the high expression and low expression groups in both tumor and non-tumor tissues.
RESULTS: Fbxw7 messenger RNA expression level in the non-tumor tissues was significantly higher than that in the tumor tissues. In the analysis of Fbxw7 expression in tumor and non-tumor tissues, disease-free survival rate in the Fbxw7 high expression group was significantly higher than that in the low expression group. In multivariable analysis, Fbxw7 low expression in both tumor and non-tumor tissue was detected as the strongest independent risk factor for HCC recurrence.
CONCLUSIONS: Low Fbxw7 expression in both tumor and non-tumor tissue may be an independent prognostic factor for tumor recurrence after hepatectomy in patients with HCC.
© 2014 Journal of Gastroenterology and Hepatology Foundation and Wiley Publishing Asia Pty Ltd.

Entities:  

Keywords:  carcinogenesis; gene expression; multicentric recurrence; prognosis

Mesh:

Substances:

Year:  2014        PMID: 24731221     DOI: 10.1111/jgh.12623

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  11 in total

1.  Loss of Fbxw7 synergizes with activated Akt signaling to promote c-Myc dependent cholangiocarcinogenesis.

Authors:  Jingxiao Wang; Haichuan Wang; Michele Peters; Ning Ding; Silvia Ribback; Kirsten Utpatel; Antonio Cigliano; Frank Dombrowski; Meng Xu; Xinyan Chen; Xinhua Song; Li Che; Matthias Evert; Antonio Cossu; John Gordan; Yong Zeng; Xin Chen; Diego F Calvisi
Journal:  J Hepatol       Date:  2019-06-11       Impact factor: 25.083

2.  FBXW7 overexpression suppresses renal cancer cell proliferation and induces apoptosis.

Authors:  Yu Fu; Youcheng Lin; Zhao Yang; Guosheng Yang; Gaoyuan Li; Yuejia Liu; Xi Tan; Yi Huang; Xun Wu; Yongqiang Wang; Hu Xiong; Meng Zhang; Lu Fang; Yukun Ge; Jun Zeng; Yangke Cai; Jian Bai; Song Wu
Journal:  Med Oncol       Date:  2015-07-11       Impact factor: 3.064

Review 3.  The roles of E3 ligases in Hepatocellular carcinoma.

Authors:  Zongdong Yu; Hong Li; Jie Zhu; Haibiao Wang; Xiaofeng Jin
Journal:  Am J Cancer Res       Date:  2022-03-15       Impact factor: 6.166

4.  Poor prognosis in cholangiocarcinoma patients with low FBXW7 expression is improved by chemotherapy.

Authors:  Norihiro Ishii; Kenichiro Araki; Takehiko Yokobori; Akira Watanabe; Mariko Tsukagoshi; Norio Kubo; Hideki Suzuki; Fumiyoshi Saito; Bolag Altan; Yasuo Hosouchi; Ken Shirabe; Hiroyuki Kuwano
Journal:  Oncol Lett       Date:  2017-03-29       Impact factor: 2.967

Review 5.  Ubiquitin-Dependent Regulation of the Mammalian Hippo Pathway: Therapeutic Implications for Cancer.

Authors:  Thanh Hung Nguyen; Jan-Michael Kugler
Journal:  Cancers (Basel)       Date:  2018-04-17       Impact factor: 6.639

6.  Inhibition of miR-103a-3p suppresses lipopolysaccharide-induced sepsis and liver injury by regulating FBXW7 expression.

Authors:  Yu-Ping Zhou; Qin Xia
Journal:  Cell Biol Int       Date:  2020-05-12       Impact factor: 3.612

Review 7.  Fbxw7 Tumor Suppressor: A Vital Regulator Contributes to Human Tumorigenesis.

Authors:  Jun Cao; Ming-Hua Ge; Zhi-Qiang Ling
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.889

8.  Reduced FBXW7 expression in pancreatic cancer correlates with poor prognosis and chemotherapeutic resistance via accumulation of MCL1.

Authors:  Norihiro Ishii; Kenichiro Araki; Takehiko Yokobori; Dorgormaa Gantumur; Takahiro Yamanaka; Bolag Altan; Mariko Tsukagoshi; Takamichi Igarashi; Akira Watanabe; Norio Kubo; Yasuo Hosouchi; Hiroyuki Kuwano; Ken Shirabe
Journal:  Oncotarget       Date:  2017-11-06

9.  Alcohol-dysregulated microRNAs in hepatitis B virus-related hepatocellular carcinoma.

Authors:  Hao Zheng; Angela E Zou; Maarouf A Saad; Xiao Qi Wang; James G Kwok; Avinaash Korrapati; Pinxue Li; Tatiana Kisseleva; Jessica Wang-Rodriguez; Weg M Ongkeko
Journal:  PLoS One       Date:  2017-05-31       Impact factor: 3.240

Review 10.  FBXW7: a critical tumor suppressor of human cancers.

Authors:  Chien-Hung Yeh; Marcia Bellon; Christophe Nicot
Journal:  Mol Cancer       Date:  2018-08-07       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.